(Q37864255)

English

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review

scientific article published on September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

0 references

1 reference

Europe PubMed Central

Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review (English)

1 reference

Europe PubMed Central

24 August 2017

type 2 diabetes

0 references

0 references

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Yu-Hung Chang

1

1 reference

Europe PubMed Central

24 August 2017

Dao-Ming Chang

2

1 reference

Europe PubMed Central

24 August 2017

Kun-Cheng Lin

3

1 reference

Europe PubMed Central

24 August 2017

Shyi-Jang Shin

4

1 reference

Europe PubMed Central

24 August 2017

Yau-Jiunn Lee

5

1 reference

Europe PubMed Central

24 August 2017

publication date

1 September 2011

1 reference

Europe PubMed Central

24 August 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

24 August 2017

27

1 reference

Europe PubMed Central

24 August 2017

6

1 reference

Europe PubMed Central

24 August 2017

515-527

1 reference

Europe PubMed Central

24 August 2017

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Retraction: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Effect of exercise training on plasma visfatin and eotaxin levels

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Plasma visfatin levels in normal weight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Effect of weight loss on proinflammatory state of mononuclear cells in obese women

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Adipokines and cardiometabolic function: How are they interlinked?

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

The relationship between visfatin and metabolic syndrome in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Increase in visfatin after weight loss induced by gastroplastic surgery

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Estimating the mean and variance from the median, range, and the size of a sample

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Skeletal muscle NAMPT is induced by exercise in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Visfatin is upregulated in type-2 diabetic rats and targets renal cells

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

The release of the adipocytokine visfatin is regulated by glucose and insulin.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

The novel adipocytokine visfatin exerts direct cardioprotective effects

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Molecular Characteristics of Serum Visfatin and Differential Detection by Immunoassays

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

21 January 2018

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum visfatin increases with progressive beta-cell deterioration

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum concentration of visfatin in obese women

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normal-weight, overweight, and obese men.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Preanalytical influences on the measurement of visfatin by enzyme immuno assay

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.1201

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.1201

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37864255&oldid=2139811388"